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Iterative catalyst controlled diastereodivergent synthesis of 
polypropionates†‡ 
D. Roke,a M. Fañanás-Mastral*a,b and B. L. Feringa*,a 
Polypropionate fragments are synthesized using a combination of a copper-catalyzed asymmetric allylic alkylation, 
ruthenium-catalyzed cross-metathesis and an iridium-catalyzed asymmetric allylic etherification. The use of  the 
appropriate chiral ligand for each catalytic reaction allows access to 1,2-hydroxymethyl arrays with good to excellent 
control over the relative and absolute configuration of the different stereocenters.
Introduction 
Polypropionates are important subunits in many polyketides, 
one of the major classes of natural products featuring a wide 
range of biological activities (Figure 1).1,2 In pharmaceutics, 
polyketides have also found various applications, being used as 
antibiotics, immunosuppressants, antiparasitics, cholesterol 
lowering drugs, and antitumor agents.3 
 
Polypropionates consist of alternating methyl- and hydroxyl-
substituted stereocenters. The combination of these two 
different motifs lead to a large number of possible distinct 
stereochemical combinations. The importance of these 
complex chemical structures has directed a lot of attention 
towards the diastereoselective and enantioselective synthesis 
of polypropionates.4 In an attempt to mimic the biosynthetic 
pathway, the stereoselective aldol reaction is arguably the 
most extensively studied method.5,6 However, a large number 
of highly successful alternative approaches has been reported 
such as crotylations,7 reductive aldol couplings8 and epoxide 
ring-opening reactions.9 Important methods for the 
asymmetric synthesis of polypropionates frequently start with 
stoichiometric amounts of chiral material, either from natural 
sources or often in the form of chiral auxiliaries which are to 
be attached and cleaved off in separate steps. 
A growing number of catalytic methods towards 
polypropionates is emerging,4 and examples include 
(organo)catalytic aldol couplings,5,10 reductive aldol 
couplings4,8,11 and catalytic crotylations.12 Although already a 
variety of useful catalytic asymmetric methods towards chiral 
propionate units exists, most of these methods are limited so 
far that only one 1,2-hydroxymethyl moiety is introduced,10-12 
making it difficult to perform these methods iteratively to 
allow the formation of polypropionates. 
 
Figure 1: a) Examples of polyketides bearing polypropionate segments (highlighted in 
red). b) Three configurations of polypropionate segments described in this paper. 
The transition metal-catalyzed asymmetric allylic substitution 
is a widely investigated reaction, which allows the formation of 
C-C, C-H, C-S, C-N and C-O bonds in a highly enantioselective 
manner.13 In particular, the SN2’-selective allylic substitution 
provides a versatile substrate which bears a stereocenter next 
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to a double bond which can be further functionalized.13,14 
Copper-catalyzed asymmetric allylic alkylations with 
organometallic reagents usually proceeds with high SN2’ 
selectivity being a powerful tool for the construction of 
optically active carbon stereocenters.15 A wide range of chiral 
ligands has been utilized for the copper-catalyzed asymmetric 
allylic alkylation, examples include phosphoramidites,16 
diphosphine,17 phosphine-phosphite18 and NHC ligands.19 
Among these different catalytic systems, the combination of 
CuBr·SMe2 with TaniaPhos L1 has emerged as an excellent 
catalyst for the introduction of the methyl unit via copper-
catalyzed AAA.17 
On the other hand different transition metals have been 
employed for the asymmetric allylic C-O bond formation 
towards branched allyl ethers and alcohols.20-28 Among these 
systems Ir/phosphoramidite complexes have emerged as very 
efficient catalysts for the SN2’-selective asymmetric allylic 
etherification.13d,f,g,23-27 Substitutions with phenoxides23 and 
alkoxides24a,b and alcohols24c have been shown to provide 
excellent results. Moreover silanoates25 and caboxylates26 can 
be introduced and even a direct hydroxylation using 
carbonates as pronucleophiles has been reported.27 
An iterative approach in which the methyl and hydroxyl 
substituents are introduced in separate allylic substitution 
steps, could be a potentially powerful approach towards 
polypropionates. A related strategy has been used before for 
the synthesis of 1,2-dihydroxy arrays23e,28 and, albeit non-
iteratively, for 1,2-aminoethyl arrays.29 However for 
polypropionates only a few sequential approaches have been 
published,30 and to the best of our knowledge a catalytic 
iterative approach in which alternating methyl and hydroxyl 
groups are sequentially introduced to arrive at the distinct 
diastereomers and enantiomers of polypropionates has not 
been reported.4 A distinct advantage of such a catalytic 
iterative approach is that it can be performed in a 
diastereodivergent way, in which the diastereoselectivity is 
controlled fully by the chiral catalyst.  
 
 
Scheme 1: Iterative catalytic approach towards polypropionates. 
Herein we present an iterative catalytic method for the 
synthesis of polypropionates in which stereocenters are 
sequentially generated using a copper-catalyzed asymmetric 
allylic alkylation, reported earlier by our group,17f in 
combination with an iridium-catalyzed asymmetric allylic 
etherification (Scheme 1).23d,e The combination of subsequent 
asymmetric allylic substitution reactions allows for the 
sequential introduction of methyl- and hydroxyl-substituted 
stereocenters. Control over the distinct configurations was 
achieved by the use of the appropriate enantiomer of the 
chiral ligand to obtain the desired stereochemistry.  After each 
new stereocenter that is introduced by a catalytic allylic 
substitution, a ruthenium-catalyzed cross-metathesis is 
performed to introduce either an allylic carbonate or allylic 
bromide to allow the next stereocenter to be introduced. 
Results and discussion 
Starting with acetal protected allyl bromide 1, the first copper-
catalyzed asymmetric allylic alkylation with MeMgBr was 
carried out using a Cu-Taniaphos catalyst to provide product 2 
with high levels of stereocontrol (anti d.r. > 99:1; syn d.r. = 
90:10, Scheme 2).17f Both syn- and anti-isomers of product 2 
can be obtained by choosing the appropriate enantiomer of 
the Taniaphos ligand L1. Pure syn-2b diastereomer was readily 
obtained by column chromatography. The configuration of the 
newly formed stereocenter is determined largely by the chiral 
catalyst, rather than the chirality present in the substrate, 
indicating a high level of catalyst control. Protecting the 
adjacent allylic hydroxyl using a dioxolane ring appeared to be 
essential, since other protecting groups gave rather low 
conversion and/or regioselectivity.17f 
 
 
Scheme 2: Asymmetric allylic alkylations of allyl bromide 1 towards products 2. 
aDiastereomeric ratio (d.r.) determined by GC-MS analysis. 
Next, both anti- and syn-products 2 were converted into the 
corresponding allyl carbonates 4 by a cross-metathesis 
reaction. Using Hoveyda-Grubbs 2nd generation catalyst and 
the readily available (Z)-but-2-ene-1,4-diyl bis(4-
methoxyphenyl) dicarbonate (3, Scheme 3), carbonates 4a and 
4b were obtained in 69% and 66% yield, respectively. 
 
 
Scheme 3: Cross-metathesis of anti- and syn-products 2 towards allyl carbonates 4. 
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Scheme 4: Asymmetric allylic etherifications of allyl carbonates 4 forming allyl ethers 5. aDiastereomeric ratio determined by GC-MS and 1H-NMR analysis of the crude product.
In the next step we explored the iridium-catalyzed asymmetric 
allylic etherification arriving at products 5 bearing a 1,3-
hydroxy-2-methyl unit, featuring three contiguous 
stereocenters (Scheme 4). A wide range of different methods 
for asymmetric allylic alkylations using O-nucleophiles have 
been reported, often giving rise to allylic ethers with excellent 
regio- and enantioselectivity.20-21,23-27 Our attention was drawn 
by one specific method reported by Han and coworkers, in 
which a decarboxylative allylic etherification was performed, 
to provide branched allylic para-methoxyphenyl ethers             
(-OPMP).23d,e In contrast to the previous asymmetric allylic 
etherifications, this method does not require the use of an 
external nucleophile, leading to higher atom efficiency. 
Moreover, the para-methoxyphenyl ethers are generally easily 
cleaved under oxidative conditions to liberate the free 
hydroxyl moiety.31 
Performing the etherification, using [Ir(dbcot)Cl]232 in the 
presence of chiral phosphoramidite ligand L2 and DBU as a 
base in THF (Scheme 4), resulted in high conversion towards 
the allylic ethers 5. To our delight, when we applied Han’s 
conditions to allylic carbonate 4a with (S,S,S)-L2, anti-anti 
isomer 5a was obtained with excellent diastereoselectivity. 
When the opposite enantiomer (R,R,R)-L2 was used, substrate 
4a was converted into anti-syn-isomer 5b. A diastereomeric 
ratio of over 20:1 was found, showing no obvious mismatch 
effect. Finally, when the asymmetric allylic etherification was 
performed on substrate 4b using ligand (S,S,S)-L2, syn-syn-
isomer 5c was obtained, again with excellent control over 
diastereoselectivity, with a diastereomeric ratio of over 20:1. 
Moreover, in all cases, the control over regioselectivity is 
perfect, as no linear product due to SN2 substitution was 
observed. 
 
To highlight the potential iteration of our method, allyl 
bromides 7 were synthesized to perform a second copper-
catalyzed asymmetric allylic alkylation. The terminal olefin was 
converted into the required allylic bromide necessary for the 
subsequent alkylation using a challenging cross-metathesis 
reaction (Scheme 5).33 Substrates 5a and 5b were converted 
into the allylic bromides 7a and 7b, respectively, with (E)-1,4-
dibromo-2-butene (6) applying Hoveyda-Grubbs 2nd generation 
catalyst. Allylic bromide 7a and 7b were obtained in 81% and 
64% yield, respectively.34 
 
 
Scheme 5: Cross-metathesis reactions to convert the terminal olefins into allylic 
bromides. aYields are based on recovered starting material. 
A second methyl substituent was introduced via a copper-
catalyzed asymmetric allylic alkylation, creating a molecule 
bearing four consecutive stereocenters (Scheme 6). When we 
subjected substrates 7 to our previously optimized conditions 
for the copper-catalyzed asymmetric allylic alkylation of 
substrate 1, high selectivity was obtained, but low rather 
conversion was observed. Therefore, a screening of 
temperatures, copper complexes and ligands was performed 
on a model substrate (see supporting information), showing 
that none of the tested systems gave better selectivity than 
our initial system consisting of CuBr·SMe2 and Taniaphos ligand 
L1. However, using this catalyst system, high conversion could 
be obtained by raising the temperature to -60 °C. When we 
subjected allylic bromide 7a to these newly optimized 
conditions using (R,R)-Taniaphos L1, nearly full conversion and 
high selectivities in the allylic alkylation towards product 8a 
bearing the anti-anti-anti configuration were obtained. This 
configuration has shown to be the most challenging 
stereochemical array to synthesize via conventional 
methods.4d,35 Remarkably, the increase in temperature from    
-80 °C to -60 °C compared to the asymmetric allylic alkylation 
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of substrate 1 did not affect the SN2’:SN2 ratio. Studies on 
copper-catalyzed asymmetric allylic alkylations on related 
structures bearing a vicinal stereocenter are very scarce. 
Notably, a recent study from our group showed that low 
regioselectivity is obtained with related substrates with other 
protecting groups at the allylic alcohol unit.17f Apart from this, 
as far as we know only a kinetic resolution of allylic substrates 
bearing an alkyl substituent at the allylic stereocenter has 
been published.36 
 
Scheme 6a,b: Copper-catalyzed asymmetric allylic alkylation of allylic bromides 7. 
aBranched to linear ratio, diastereomeric ratio and conversion were determined by 1H-
NMR analysis of the crude product. bFor products 8b and 8c, after one day and with 5 
mol% of copper, 30% and 50% conversion was obtained, respectively. 
Product 8b bearing anti-syn-anti-configuration was obtained 
with excellent selectivities and high conversion, although 
prolonged reaction times and increased catalyst loading are 
needed. Even though the configuration of the newly 
introduced substituent in product 8a and 8b are both anti with 
respect to the vicinal stereocenter, it is clear that the reaction 
towards product 8a proceeds faster (1 d versus 3 d) and with 
lower catalyst loading (5 mol% versus 7.5 mol%). In this case it 
seems that the interaction with the more remote stereocenter 
(1,3-methyl-methyl interaction) has a rather large influence on 
the reactivity and that the 1,3-syn-configuration in product 8a 
is preferred over the 1,3-anti-configuration in product 8b. A 
similar effect was observed in the synthesis of 
deoxypropionates reported by Hanessian and coworkers and it 
was hypothesized that syn-pentane interactions37 would be 
minimized in the CuIII-intermediate when the methyl and CuIII-
complex are syn to each other, leading to the syn-product 
(Figure 2).38 When these substituents are anti to each other 
(leading to anti-products), these interactions are maximized. It 
is however not clear what the effect of the bulky –OPMP 
substituent is and how this changes the 1,3-interaction. 
The new protocol presented here was also effective for the 
even more challenging methylation towards the anti-anti-syn-
8c stereoisomer. In this case, the methyl unit that had to be 
introduced is syn with respect to the  vicinal stereocenter 
already present. As shown for substrate 1, a mismatch effect is 
expected due to unfavorable steric interactions of the 
substrate with the catalyst when a methyl substituent is 
introduced with a 1,2-syn-configuration. Moreover, also the 
1,3-methyl-methyl interactions are unfavorable, making this 
diastereomer the most difficult one to access. Despite the 
highly unfavorable interactions, high regioselectivity (b:l >11:1) 
was observed towards product 1,2-syn-8c when we subjected 
substrate 7a to our reaction conditions, using (S,S)-Taniaphos 
L1. Although a slightly reduced stereoselectivity was observed 
in this case, most probably arising from competing substrate 
control, the anti-anti-syn isomer 8c could still be obtained with 
good selectivity (dr = 4:1). It is important to note that the small 
amount of minor stereoisomer was readily removed by column 
chromatography to provide product 8c as a single enantiomer 
in 50% yield. 
 
 
Figure 2: Syn-pentane interactions of 1,3-dimethyl moieties in a diamond lattice. 
Ligands on copper are not presented for clarification. 
To overcome the mismatch effect observed on the allylic 
alkylation towards product syn-8c which resulted in a decrease 
in diastereoselectivity, an alternative approach was studied. In 
previous work, we showed that the presence of the dioxolane 
ring is essential to obtain high selectivity in an asymmetric 
allylic alkylation towards 1,2-hydroxymethyl units.17f We 
envisioned that installing a dioxane ring in our system might 
also improve the stereoselectivity. A sequence consisting of 
deprotection-protection steps starting from 5a afforded olefin 
9 in 59% overall yield (Scheme 7). Next, a ruthenium-catalyzed 
cross-metathesis was performed with (E)-1,4-dibromo-2-
butene and Hoveyda-Grubbs 2nd generation catalyst to provide 
allylic bromide 10. 
 
Scheme 7: Synthesis of allylic bromide 10. 
This adapted strategy was highly rewarding as the copper-
catalyzed asymmetric allylic alkylation on allylic bromide 10 
shows that excellent stereoselectivity and regioselectivity are 
obtained towards product 11 (Scheme 8). Product 11 has the 
same anti-anti-syn configuration as product 8c, but shows a 
near perfect degree of stereocontrol, likely due to the 
protection of the hydroxyl moiety as part of the dioxane ring. 
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Although this reaction suffers from rather low conversion, 
starting material can be readily recovered and resubmitted to 
the reaction. These results show that the three polypropionate 
segments bearing anti-anti-anti, anti-syn-anti and anti-anti-syn 
stereochemical units can be obtained in a catalytic iterative 




Scheme 8: Copper-catalyzed asymmetric allylic alkylation towards product 11. 
Conversion, diastereomeric ratio and branched to linear ratio are based on 1H-NMR 
analysis of the crude product. 
Conclusions 
In summary, a new method for the iterative catalyst controlled 
diastereodivergent synthesis of polypropionates is developed 
by combining a copper-catalyzed asymmetric allylic alkylation 
with a ruthenium-catalyzed cross-metathesis and an iridium-
catalyzed asymmetric allylic etherification. Both methyl- and 
hydroxyl-substituted stereocenters are introduced with high 
regio- and diastereoselectivity. In each allylic substitution, 
despite the presence of (multiple) stereocenters, nearly full 
control over selectivity by the chiral catalyst is observed and 
the ability of synthesizing several diastereomers under catalyst 
control has been demonstrated with the preparation of anti-
anti-anti-, anti-syn-anti- and anti-anti-syn-isomers. These 
synthetically valuable fragments can be accessed with 
excellent selectivities by the use of the appropriate 
enantiomer of the ligand in each catalytic reaction. Moreover, 
remarkably high selectivity towards the branched product was 
observed in the copper-catalyzed asymmetric allylic alkylation. 
Acknowledgements 
Financial support from The Netherlands Organization for 
Scientific Research (NWO-CW), the National Research School 
of Catalysis (NRSC-C) and the Ministry of Education, Culture 
and Science (Gravitation Program 024.001.035) is gratefully 
acknowledged. 
Experimental section 
Typical procedure for cross metathesis of olefins 2 with 
dicarbonate 3. In a Schlenk tube equipped with septum and 
stirring bar, Hoveyda-Grubbs 2nd generation catalyst (7.68 
μmol, 4,81 mg), dicarbonate 3 (0.256 mmol, 99.4 mg) and 
olefin 2 (0.256 mmol, 40 mg) were dissolved in dry degassed 
toluene (2.5 mL) and stirred under nitrogen atmosphere at 
70°C. After 5 h, a second portion of Hoveyda-Grubbs 2nd 
generation catalyst (5.20 μmol, 3.21 mg) and dicarbonate 3 
(0.256 mmol, 99.4 mg) were added. After 18 h, water was 
added and the aqueous layer was extracted 3 times with 
CH2Cl2. The organic layers were combined and dried over 
anhydrous Na2SO4, filtered and concentrated in vacuo. The 
residue was purified by flash chromatography to yield the 
corresponding carbonate 4. 
(S,E)-4-((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)pent-2-en-1-yl (4-
methoxyphenyl) carbonate (4a) Purification by column 
chromatography (SiO2 pentane/diethyl ether 3:1) afforded 4a 
(65.5 mg, 69%) as a colorless oil. [α]D20 = -2.4° (c = 1.0 in 
CHCl3). 1H NMR (400 MHz, CDCl3): δ 7.09 (m, 2H), 6.88 (m, 2H), 
5.91 (dd, J = 7.1, 15.6 Hz, 1 H) 5.71 (dt, J = 15.6, 6.5 Hz, 1H), 
4.71 (m, 2H),3.99 (m, 2H), 3.80 (s, 3H), 3.63 (dd, J = 6.1, 13.3 
Hz, 1H), 1.41 (s, 1H), 1.36 (s, 1H), 1.03 (d, J = 6.9 Hz, 3H). 13C 
NMR (101 MHz, CDCl3): δ 157.4, 153.9, 144.7, 138.4, 123.5, 
121.9, 114.4, 109.1, 79.1, 69.1, 67.4, 55.6, 39.5, 26.5, 25.5, 
15.6. HRMS (ESI+, m/z): Calcd for C18H25O6 [M+H+]: 337.1641, 
found: 337.1646. 
(R,E)-4-((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)pent-2-en-1-yl (4-
methoxyphenyl) carbonate (4b) Purification by column 
chromatography (SiO2 pentane/diethyl ether 3:1) afforded 4b 
(136.9 mg, 66%) as a colorless oil. [α]D20 = +15.2° (c = 1.0 in 
CHCl3). 1H NMR (400 MHz, CDCl3): δ 7.09 (m, 2H), 6.88 (m, 2H), 
5.74 (m, 2H), 4.67 (d, J = 5.3 Hz, 2H), 3.94 (m, 2H), 3.79 (s, 3H), 
3.64 (m, 1H), 2.39 (m, 1H), 1.41 (s, 1H), 1.35 (s, 1H), 1.11 (d, J = 
6.8 Hz, 3H). 13C NMR (101 MHz, CDCl3): δ 157.4, 153.9, 144.7, 
137.8, 124.0, 121.8, 144.4, 109.1, 79.1, 68.9, 67.4, 55.6, 40.3, 
26.7, 25.4, 16.2. HRMS (ESI+, m/z): Calcd for C18H25O6 [M+H+]: 
337.1643, found: 337.1646. 
Typical procedure for iridium-catalyzed allylic etherification 
of carbonates 4. In a Schlenk tube equipped with septum and 
stirring bar, [Ir(dbcot)Cl]2 (4 μmol, 3.46 mg) and L2 (8 μmol, 5.0 
mg) were stirred for 10 min in THF (0.5 mL) under nitrogen 
atmosphere until a homogenous orange solution was 
obtained. DBU (0.2 mmol, 30 μmol) was added and the color 
changed to light yellow. Carbonate 4 (0.2 mmol, 67.3 mg) in 
THF (1.0 mL) was added and the mixture was stirred overnight 
at 60 °C. Water (1.5 ml) was added and the aqueous layer was 
extracted with Et2O (3 x 1.5 ml). The combined organic layers 
were dried over anhydrous Na2SO4, filtered and concentrated 
in vacuo. The residue was purified by flash chromatography to 
yield compounds 5. 
(S)-4-((2S,3S)-3-(4-Methoxyphenoxy)pent-4-en-2-yl)-2,2-
dimethyl-1,3-dioxolane (5a) Purification by column 
chromatography (SiO2, pentane/diethyl ether 10:1) afforded 
5a (197.9 mg, 68%) as a colorless oil. [α]D20 = -2.4° (c =  1.0 in 
CHCl3). 1H NMR (400 MHz, CDCl3): δ 6.89 – 6.83 (m, 2H), 6.83 – 
6.77 (m, 2H), 5.86 (ddd, J = 6.3, 10.7, 17.2 Hz, 1H), 5.31 (dd, J = 
8.8, 14.0 Hz, 2H), 4.79 (dd, J = 4.8, 5.7 Hz, 1H), 4.06 – 3.98 (m, 
2H), 3.76 (s, 3H), 3.72 – 3.65 (m, 1H), 2.27 – 2.15 (m, 1H), 1.41 
(s, 3H) 1.36 (s, 3H), 0.93 (d, J = 6.9 Hz, 3H). 13C NMR (101 MHz, 
CDCl3): δ 153.8, 152.1, 134.8, 118.1, 117.1, 114.4, 108.6, 80.0, 
76.6, 67.6, 55.7, 40.6, 26.7, 25.7, 10.1. HRMS (ESI+, m/z): Calcd 
for C17H25O4 [M+H+]: 293.1745, found: 293.1747. 
(S)-4-((2S,3R)-3-(4-Methoxyphenoxy)pent-4-en-2-yl)-2,2-
dimethyl-1,3-dioxolane (5b) Purification by column 
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chromatography (SiO2, pentane/diethyl ether 10:1) afforded 
5b (217.2 mg, 74%) as a pale yellow oil. [α]D20 = -2.8° (c = 1.0 in 
CHCl3). 1H NMR (400 MHz, CDCl3): δ 6.91 – 6.76 (m, 4H), 5.84 
(ddd, J = 17.3, 10.7, 5.3 Hz, 1H), 5.27 – 5.20 (m, 2H), 4.85 – 
4.81 (m, 1H), 4.17 (td, J = 7.9, 6.1 Hz, 1H), 4.02 (dd, J = 8.0, 6.0 
Hz, 1H), 3.76 (s, 3H), 3.67 (t, J = 7.9 Hz, 1H), 1.95 – 1.86 (m, 
1H), 1.41 (s, 3H), 1.32 (s, 3H), 0.96 (d, J = 7.0 Hz, 3H). 13C NMR 
(101 MHz, CDCl3): δ 153.9, 152.8, 136.8, 117.4, 116.6, 114.4, 
108.5, 79.4, 77.0, 67.7, 55.7, 42.1, 26.7, 25.7, 8.7. HRMS (ESI+, 
m/z): Calcd for C17H25O4 [M+H+]: 293.1747, found: 293.1748. 
(S)-4-((2R,3S)-3-(4-Methoxyphenoxy)pent-4-en-2-yl)-2,2-
dimethyl-1,3-dioxolane (5c) Purification by column 
chromatography (SiO2, pentane/diethyl ether 10:1) afforded 5c 
(38.9 mg, 67%) as a colorless oil. [α]D20 = +7.2° (c = 1.0 in CHCl-
3). 1H NMR (400 MHz, CDCl3): δ 6.84 – 6.77 (m, 4H), 5.89 – 5.79 
(m, 1H), 5.29 – 5.22 (m, 2H), 4.50 (t, J = 5.1 Hz, 1H), 4.13 (dd, J 
= 13.8, 6.8 Hz, 1H), 4.04 (dd, J = 8.1, 6.0 Hz, 1H), 3.76 (t, J = 8 
Hz, 1H), 3.75 (s, 3H), 2.03 – 1.95 (m, 1H), 1.37 (s, 3H), 1.35 (s, 
3H), 1.13 (d, J = 6.9 Hz, 3H). 13C NMR (101 MHz, CDCl3): δ 
153.9, 152.1, 135.7, 117.7, 117.0, 114.5, 105.3, 80.9, 77.1, 
68.0, 55.6, 41.1, 26.6, 25.7, 11.4. HRMS (ESI+, m/z): Calcd for 
C17H25O4 [M+H+]: 293.1747, found: 293.1748. 
Typical procedure for cross-metathesis of olefins 5 with (E)-
1,4-dibromobut-2-ene. In a Schlenk tube equipped with 
septum and stirring bar, Hoveyda-Grubbs 2nd generation 
catalyst (0.015 mmol, 9.40 mg), (E)-1,4-dibromobut-2-ene (2.5 
mmol, 577.3 mg) and olefin 5 (0.5 mmol, 146.2 mg) were 
dissolved in toluene (5 mL) and the mixture was stirred under 
nitrogen atmosphere at 80 °C. After 5 h, a second portion of 
Hoveyda-Grubbs 2nd generation catalyst (0.010 mmol, 6.27 
mg) was added. After 18 h, water (4 ml) was added and the 
aqueous layer was extracted with CH2Cl2 (3 x 3 ml). The 
combined organic layers were and dried over anhydrous 
Na2SO4, filtered and concentrated in vacuo. The residue was 
purified by flash chromatography to yield the corresponding 
allyl bromides 7. 
(S)-4-((2S,3S,E)-6-Bromo-3-(4-methoxyphenoxy)hex-4-en-2-
yl)-2,2-dimethyl-1,3-dioxolane (7a) Purification by column 
chromatography (SiO2, pentane/ethyl acetate 15:1) afforded 
7a (130.6 mg, 56%) as a pale yellow oil. [α]D20 = +9.0° (c = 1.0 in 
CHCl3). 1H NMR (400 MHz, CDCl3): δ 6.86 – 6.78 (m, 4H), 6.00 
(dt, J = 15.1, 7.5 Hz, 1H), 5.83 (dd, J = 15.4, 6.3 Hz, 1H), 4.87 – 
4.83 (m, 1H), 4.04 (dd, J = 7.8, 6.0 Hz, 1H), 3.99 – 3.92 (m, 2H), 
3.76 (s, 3H), 3.65 (dd, J = 9.9, 5.5 Hz, 1H), 2.26 – 2.17 (m, 1H), 
1.41 (s, 3H), 1.37 (s, 3H), 0.92 (d, J = 6.9 Hz, 3H). 13C NMR (101 
MHz, CDCl3): δ 154.0, 151.8, 132.0, 129.6, 117.1, 114.5, 108.8, 
78.4, 76.6, 67.9, 55.7, 41.1, 31.8, 26.8, 25.7, 10.1. HRMS (ESI+, 
m/z): Calcd for C18H26BrO4 [M+H+]: 385.1009, found: 385.1002. 
(S)-4-((2S,3R,E)-6-Bromo-3-(4-methoxyphenoxy)hex-4-en-2-
yl)-2,2-dimethyl-1,3-dioxolane (7b) Purification by column 
chromatography (SiO2, pentane/ethyl acetate 15:1) afforded 
7b (114.9 mg, 54%) as a pale yellow oil. [α]D20 = -22.0° (c = 1.0 
in CHCl3). 1H NMR (400 MHz, CDCl3): δ 6.89 – 6.77 (m, 1H), 5.90 
(dt, J = 7.3, 6.8 Hz, 1H), 5.79 (dd, J = 15.4, 5.0 Hz, 1H), 4.89 – 
4.86 (m, 1H), 4.14 (dt, J = 14.1, 7.1 Hz, 1H), 4.02 (dd, J = 8.0, 6.0 
Hz, 1H), 3.95 (d, J = 7.3 Hz, 1H), 3.76 (s, 3H), 3.65 (t, J = 7.8 Hz, 
1H), 1.93 – 1.84 (m, 1H), 1.41 (s, 3H), 1.31 (s, 3H), 0.95 (d, J = 
7.0 Hz, 3H). 13C NMR (101 MHz, CDCl3): δ 154.1, 152.5, 134.1, 
128.2, 117.4, 114.5, 108.6, 78.0, 76.9, 67.8, 55.7, 42.2, 31.9, 
26.9, 25.7, 8.9. HRMS (ESI+, m/z): Calcd for C18H26BrO4 [M+H+]: 
385.1009, found: 385.1002. 
Typical procedure for asymmetric allylic alkylations of allylic 
bromides 7. In a Schlenk tube equipped with stirring bar and 
septum, CuBr·SMe2 (0.010 mmol, 2.06 mg) and the 
corresponding ligand (0.012 mmol) were dissolved in CH2Cl2 
(0.8 ml) and the mixture was stirred under nitrogen 
atmosphere at room temperature for 15 min. The mixture was 
cooled to -60 °C and MeMgBr (0.2 ml, 3M solution in Et2O) was 
added dropwise. Allyl bromide 7 (0.2 mmol, 77.1 mg) was then 
added dropwise as a solution in CH2Cl2 (0.32 ml) over 1 h using 
a syringe pump. Once the addition was complete the resulting 
mixture was further stirred at -60 °C for 3 days. The reaction 
was quenched by addition of MeOH (0.2 ml) and the mixture 
was allowed to reach rt. Then, saturated aqueous NH4Cl 
solution (2 ml) was added to the mixture. The organic phase 
was separated, and the resulting aqueous layer was extracted 
with CH2Cl2 (3 x 2 ml). The organic layers were combined and 
dried over anhydrous Na2SO4, filtered and concentrated in 
vacuo. The residue was purified by flash chromatography to 
yield the corresponding products 8. 
(S)-4-((2S,3S,4S)-3-(4-Methoxyphenoxy)-4-methylhex-5-en-2-
yl)-2,2-dimethyl-1,3-dioxolane (8a) Purification by column 
chromatography (SiO2, pentane/ethyl acetate 15:1) afforded 
8a (48.9 mg, 77%) as a colorless oil. [α]D20 = +23.4° (c = 1.0 in 
CHCl3). 1H NMR (400 MHz, CDCl3): δ 6.88 – 6.77 (m, 4H), 6.01 – 
5.91 (m, 1H), 5.07 (d, J = 16.9 Hz, 1H), 5.01 (dd, J = 10.3, 1.0 Hz, 
1H), 4.31 (dd, J = 13.9, 6.3 Hz, 1H), 4.08 (t, J = 5.2 Hz, 1H), 3.89 
(dd, J = 8.1, 6.3 Hz, 1H), 3.76 (s, 3H), 3.63 (t, J = 7.9 Hz, 1H), 
2.73 – 2.63 (m, 1H), 2.34 – 2.24 (m, 1H), 1.40 (s, 3H), 1.34 (s, 
3H), 1.11 (d, J = 6.9 Hz, 3H), 0.92 (d, J = 7.0 Hz, 3H). 13C NMR 
(101 MHz, CDCl3): δ 153.6, 153.5, 140.7, 116.6, 114.7, 114.6, 
114.6, 108.2, 83.5, 76.1, 66.6, 56.7, 40.3, 38.2, 26.5, 25.4, 17.9, 
11.3. HRMS (ESI+, m/z): Calcd for C19H28O4Na [M+Na+]: 
343.1880, found: 343.1880 
(S)-4-((2S,3R,4R)-3-(4-Methoxyphenoxy)-4-methylhex-5-en-2-
yl)-2,2-dimethyl-1,3-dioxolane (8b) Purification by column 
chromatography (SiO2, pentane/ethyl acetate 15:1) afforded 
8b (48.9 mg, 77%) as a colorless oil. [α]D20 = +2.2° (c = 1.0 in 
CHCl3). 1H NMR (400 MHz, CDCl3): δ 6.98 – 6.92 (m, 2H), 6.79 – 
6.74 (m, 2H), 5.80 (ddd, J = 17.6, 10.3, 7.5 Hz, 1H), 5.06 (dd, J = 
17.2, 1.2 Hz, 1H), 4.93 (d, J = 10.3 Hz, 1H), 4.34 (dd, J = 8.3, 1.8 
Hz, 1H), 3.99 – 3.91 (m, 2H), 3.75 (s, 3H), 3.58 – 3.52 (m, 1H), 
2.63 – 2.53 (m, 1H), 2.00 – 1.91 (m, 1H), 1.40 (s, 3H), 1.24 (s, 
3H), 1.02 (d, J = 6.9 Hz, 3H), 0.94 (d, J = 6.9, 3H). 13C NMR (101 
MHz, CDCl3): δ 154.3, 153.4, 141.4, 117.2, 114.5, 114.3, 108.6, 
81.8, 77.2, 68.5, 55.7, 40.8, 39.3, 27.0, 25.6, 16.6, 9.1. HRMS 
(ESI+, m/z): Calcd for C19H28O4Na [M+Na+]: 343.1880, found: 
343.1879. 
(S)-4-((2S,3S,4R)-3-(4-Methoxyphenoxy)-4-methylhex-5-en-2-
yl)-2,2-dimethyl-1,3-dioxolane (8c) Purification by column 
chromatography (SiO2, pentane/ethyl acetate 15:1) afforded 
8c (17.9 mg, 50%) as a colorless oil. [α]D20 = -2.4° (c = 1.0 in 
CHCl3). 1H NMR (400 MHz, CDCl3): δ 6.90 – 6.83 (m, 2H), 6.82 – 
6.77 (m, 2H), 5.82 (ddd, J = 17.4, 10.2, 8.6 Hz, 1H), 5.12 (dd, J = 
Journal Name  ARTICLE 
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 7  
Please do not adjust margins 
Please do not adjust margins 
17.6, 1.6 Hz, 1H), 5.03 (dd, J = 10.3, 1.7 Hz, 1H), 4.30 (q, J = 7.1 
Hz, 1H), 4.14 (dd, J = 8.2, 3.4 Hz, 1H), 3.95 (dd, J = 8.1, 6.1 Hz, 
1H), 3.76 (s, 2H), 3.58 (t, J = 8.0 Hz, 1H), 2.69 (h, J = 7.2 Hz, 1H), 
2.25 (td, J = 7.0, 3.4 Hz, 1H), 1.40 (s, 3H), 1.36 (s, 3H), 1.09 (d, J 
= 6.7 Hz, 3H), 0.92 (d, J = 7.1 Hz, 3H). 13C NMR (101 MHz, 
CDCl3): δ 153.6, 153.4, 141.1, 116.5, 115.0, 114.6, 108.2, 82.8, 
76.1, 67.4, 55.7, 41.0, 38.6, 26.5, 25.6, 17.7, 11.3. HRMS (ESI+, 
m/z): Calcd for C19H28O4Na [M+Na+]: 343.1880, found: 
343.1881. 
(((4S,5S,6S)-6-((R)-But-3-en-2-yl)-2,2,5-trimethyl-1,3-dioxan-
4-yl)methoxy)(tert-butyl)diphenylsilane (11) In a Schlenk tube 
equipped with stirring bar and septum, CuBr·SMe2 (0.0050 
mmol, 1.00 mg) and (S,S)-L1 (0.0060 mmol, 4.13 mg) were 
dissolved in CH2Cl2 (1.0 ml) and the mixture was stirred under 
nitrogen atmosphere at room temperature for 15 min. The 
mixture was cooled to -78 °C and MeMgBr (0.1 ml, 3M solution 
in Et2O) was added dropwise. Allylic bromide 10 (0.1 mmol, 
51.8 mg) was then added dropwise as a solution in CH2Cl2 (0.5 
ml) over 1 h using a syringe pump. Once the addition was 
complete the resulting mixture was further stirred at -78 °C for 
16 h. The reaction was quenched by addition of MeOH (0.1 ml) 
and the mixture was allowed to reach rt. Then, saturated 
aqueous NH4Cl solution (2 ml) was added to the mixture. The 
organic phase was separated, and the resulting aqueous layer 
was extracted with CH2Cl2 (3 x 2 ml). The organic layers were 
combined and dried over anhydrous Na2SO4, filtered and 
concentrated in vacuo. The residue was purified by flash 
chromatography (SiO2, pentane/Et2O 20:1) to afford syn-11a 
(23%, 10.5 mg) as a colorless oil. [α]D20 = + 6.8° (c = 0.5 in CHCl-
3) 1H NMR (400 MHz, CDCl3) δ 7.76 – 7.67 (m, 4H), 7.44 – 7.33 
(m, 6H), 5.85 (ddd, J = 17.0, 10.5, 9.1 Hz, 1H), 5.04 – 4.92 (m, 
2H), 3.79 – 3.70 (m, 2H), 3.54 – 3.48 (m, 1H), 3.36 (dd, J = 10.4, 
2.1 Hz, 1H), 2.46 – 2.36 (m, 1H), 1.67 (ddd, J = 16.9, 6.6, 3.8 Hz, 
1H), 1.38 (s, 6H), 1.06 (d, J = 6.1 Hz, 3H), 1.05 (s, 9H), 0.70 (d, J 
= 6.6 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 139.9, 135.8, 129.4, 
127.5, 114.7, 112.9, 97.6, 75.4, 65.7, 39.5, 32.0, 29.9, 26.8, 
19.4, 19.3, 18.0, 11.5. HRMS (ESI+, m/z): Calcd for 
C28H40O3SiNa [M+Na+]: 475.2639, found: 475.2630. 
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